Streibel, Yannik
Breckwoldt, Michael O.
Hunger, Jessica
Pan, Chenchen
Fischer, Manuel
Turco, Verena
Boztepe, Berin
Fels-Palesandro, Hannah
Scheck, Jonas G.
Sturm, Volker
Karimian-Jazi, Kianush
Agardy, Dennis A.
Annio, Giacomo
Mustapha, Rami
Soni, Shreya S.
Alasa, Abdulrahman
Weidenfeld, Ina
Rodell, Christopher B.
Wick, Wolfgang
Heiland, Sabine
Winkler, Frank
Platten, Michael
Bendszus, Martin
Sinkus, Ralph
Schregel, Katharina
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Project ID 404521405, SFB1389, Project ID 404521405, SFB1389, grant no. 451894423, Project ID 404521405, SFB1389, Project ID 404521405, SFB1389, Project ID 404521405, SFB1389, Project ID 404521405, SFB1389)
Else Kröner-Fresenius-Stiftung (2017-A25, 2019_EKMS.23)
Deutsche Krebshilfe (Mildred-Scheel doctoral program, grant no. 70113515)
EU Horizon TMA MSCA Postdoctoral Fellowship Award (grant no. 101068340)
National Institutes of Health (R35GM147184)
Dr. Rolf M. Schwiete Foundation
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (Sonderförderlinie ‘Neuroinflammation’)
German Ministry of Education and Science (National Center for Tumor Diseases Heidelberg NCT 3.0 program ‘Precision immunotherapy of brain tumors’)
ITMO Cancer Aviesan INSERM (cancer grant 2020 DESP/PB no. 241)
Daimler und Benz Stiftung (grant no. 32-97/21)
Medizinischen Fakultät Heidelberg, Universität Heidelberg (Olympia Morata program)
Universitätsklinikum Heidelberg
Article History
Received: 13 March 2024
Accepted: 2 July 2024
First Online: 6 July 2024
Competing interests
: The authors declare no competing interests.